Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Neomycin

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

Neomycin

EINECS 215-773-1
CAS No. 1404-04-2 Density 1.616 g/cm3
PSA 602.05000 LogP -3.40950
Solubility N/A Melting Point 250 °C (decomp)
Formula C23H46N6O13 Boiling Point 927.064 °C at 760 mmHg
Molecular Weight 614.31 Flash Point 514.47 °C
Transport Information N/A Appearance N/A
Safety 22-36/37-45 Risk Codes 42/43
Molecular Structure Molecular Structure of 1404-04-2 (NEOMYCIN SULFATE) Hazard Symbols Xn
Synonyms

Bycomycin;Fradiomycin;Jernadex;Myacyne;Neomas;Neomin;Pimavecort;Vonamycin Powder V;

 

Neomycin History

  Neomycin (CAS NO.1404-04-2) was discovered in 1949 by the microbiologist Selman Waksman and his student Hubert Lechevalier at Rutgers University. It is produced naturally by the bacterium .

Neomycin Consensus Reports

  Neomycin (CAS NO.1404-04-2) is reported in EPA TSCA Inventory.

Neomycin Specification

The Neomycin, with the CAS registry number 1404-04-2, is also known as Bykomycin. It's classification codes are Anti-Bacterial Agents; Anti-Infective Agents; Drug / Therapeutic Agent; Enzyme Inhibitors; Human Data; Mutation Data; Natural Product; Protein Synthesis Inhibitors. This chemical's molecular formula is C23H46N6O13 and molecular weight is 614.31. What's more, its systematic name is called (1R,2R,3S,4R,6S)-4,6-Diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-β-L-idopyranosyl)-β-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-α-D-glucopyranoside. Neomycin is an aminoglycoside antibiotic found in many topical medications such as creams, ointments, and eyedrops. Neomycin is overwhelmingly used as a topical preparation, such as Neosporin. This chemical can also be given oraly, where it is usually combined with other antibiotics. It has also been used to treat small intestinal bacterial overgrowth.

Physical properties about Neomycin are: (1)ACD/LogP: -5.956; (2)# of Rule of 5 Violations: 3; (3)ACD/LogD (pH 5.5): -13.82; (4)ACD/LogD (pH 7.4): -12.21; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 1.00; (9)#H bond acceptors: 19; (10)#H bond donors: 19; (11)#Freely Rotating Bonds: 22; (12)Polar Surface Area: 353.11 Å2; (13)Index of Refraction: 1.675; (14)Molar Refractivity: 142.896 cm3; (15)Molar Volume: 380.352 cm3; (16)Polarizability: 56.648×10-24cm3; (17)Surface Tension: 103.90 dyne/cm; (18)Density: 1.616 g/cm3; (19)Flash Point: 514.47 °C; (20)Enthalpy of Vaporization: 153.02 kJ/mol; (21)Boiling Point: 927.064 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25 °C.

You can still convert the following datas into molecular structure:
(1) SMILES: O([C@H]3[C@H](O[C@@H]2O[C@H](CO)[C@@H](O[C@H]1O[C@@H](CN)[C@@H](O)[C@H](O)[C@H]1N)[C@H]2O)[C@@H](O)[C@H](N)C[C@@H]3N)[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4N)CN
(2) InChI: InChI=1S/C23H46N6O13/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22/h5-23,30-36H,1-4,24-29H2/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1
(3) InChIKey: PGBHMTALBVVCIT-VCIWKGPPSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
human TDLo unreported 57mg/kg (57mg/kg) SENSE ORGANS AND SPECIAL SENSES: CHANGES IN COCHLEAR STRUCTURE OR FUNCTION: EAR

KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"
Annals of Internal Medicine. Vol. 66, Pg. 1052, 1967.
mouse LD50 intraperitoneal 116mg/kg (116mg/kg)   "Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 664, 1978.
mouse LD50 intravenous 27600ug/kg (27.6mg/kg)   Antibiotiki. Vol. 21, Pg. 532, 1976.
mouse LD50 oral 2880mg/kg (2880mg/kg)   "Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 664, 1978.
mouse LD50 subcutaneous 275mg/kg (275mg/kg)   Antibiotiki. Vol. 17, Pg. 522, 1972.
rat LD50 oral 2750mg/kg (2750mg/kg)   Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971.
rat LD50 subcutaneous 633mg/kg (633mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 176, Pg. 59, 1968.
women TDLo oral 220mg/kg/2D (220mg/kg) KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED

SENSE ORGANS AND SPECIAL SENSES: CHANGE IN ACUITY: EAR

KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"
Laryngoscope. Vol. 78, Pg. 1734, 1968.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1404-04-2